Abstract
Microsatellite instability (MSI) is caused by the dysfunction of mismatch repair genes, such as hMLH1, hMSH2. Loss of hMLH1 expression and methylation of CpG sites in hMLH1 promoter are frequently present in sporadic colorectal cancer with MSI. In this study, by transient transfection assay with constructs containing different lengths of hMLH1 promoter and a luciferase reporter gene, we located a proximal region of hMLH1 promoter, which plays a main role in regulating the gene. The fact that luciferase activities were high in all host cell lines regardless of their hMLH1 expression levels indicates that the transcription machinery is intact even in non-expressing cells. When hMLH1 promoter was in vitro methylated before transfection, the luciferase activities in the transfectants were significantly reduced. This observation indicates that methylation causes the inhibition of hMLH1 promoter activity. By electrophoretic mobility shift assay (EMSA), we identified a CCAAT box in this region, which specifically bound transcription factor CBF. Mutations in CCAAT box not only inhibited its binding to CBF factor, but also reduced its ability to drive the expression of luciferase gene. The role of CBF in activating transcription was further substantiated by inhibition of promoter activity with a plasmid expressing a dominant negative CBF-B mutant. Methylation at a CpG site two base pairs upstream of the CCAAT box inhibited the binding of CBF to CCAAT box. We conclude that methylation of an adjacent CpG site inhibits binding of the CBF transcription to the corresponding CCAAT box, and is one of the causes of hMLH1 gene silencing in colon cancer cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin J-P, Jarvinen H, Powell SM, Jen J, Hamilton SR, Petersen GH, Kinzler KW, Vogelstein B, de la Chapelle A . 1993 Science 260: 812–816
Andrews NC, Faller DV . 1991 Nucl. Acids Res. 19: 2499
Cunningham JM, Chrislensen ER, Tester D, Kim C-Y, Roche PC, Burgart LJ, Thibodeau SN . 1998 Cancer Res. 58: 3455–3460
Currie RA . 1997 J. Biol. Chem. 272: 30880–30888
Deng G, Chen A, Hong J, Chae HS, Kim YS . 1999 Cancer Res. 59: 2029–2033
Dobrovic A, Simpfendorfer D . 1997 Cancer Res. 57: 3347–3350
Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DSR, Gnarra JR, Linehan WM, Baylin SB . 1994 Proc. Natl. Acad. Sci. USA 91: 9700–9704
Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D, Baylin SB . 1995 Cancer Res. 55: 4525–4530
Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa J-PJ, Markowitz S, Willson JKV, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA, Baylin SB . 1998 Proc. Natl. Acad. Sci. USA 95: 6870–6875
Hiltunen MO, Alhonen L, Koistinaho J, Myohanen S, Paakkonen M, Marin S, Kosma VM, Janne J . 1997 Int. J. Cancer 70: 644–648
Hu Q, Maity SN . 2000 J. Biol. Chem. 275: 4435–4444
Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB . 1994 Nat. Genet. 7: 536–540
Jones PA, Laird PW . 1999 Nat. Genet. 21: 163–166
Kanai Y, Ushijima S, Hui AM, Ochiai A, Tsuda H, Sakamoto M, Hirohashi S . 1997 Int. J. Cancer 71: 355–359
Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R . 1997 Cancer Res. 57: 808–811
Kinzler KA, Vogelstein B . 1996 Cell 87: 159–170
Kominato Y, Tsuchiya T, Hata N, Takizawa H, Yamamoto F . 1997 J. Biol. Chem. 272: 25890–25898
Mantovani R . 1998 Nucl. Acids Res. 26: 1135–1143
Mantovani R, Li X-Y, Pessara U, van Huisjduijnen RH, Benoist C, Mathis D . 1994 J. Biol. Chem. 269: 20340–20346
Marziali G, Perrotti E, Ilari R, Testa U, Caccia EM, Battistini A . 1997 Mol. Cell. Biol. 17: 1387–1395
Mathey-Prevot B, Andrews NC, Murphy HS, Kreissan SG, Nathan DG . 1990 Proc. Natl. Acad. Sci. USA 87: 5046–5050
Orita T, Shimozaki K, Murakami H, Nagata S . 1997 J. Biol. Chem. 272: 23216–23223
Papadopoulos N, Nicolaides NC, Wei Y-F, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomaki P, Mecklin J-P, de la Chapelle A, Kinzler KW, Vogelstein B . 1994 Science 263: 1625–1629
Qian XC, Brent TP . 1997 Cancer Res. 57: 3672–3677
Sinha S, Kim I-S, Sohn K-Y, de Crombrugghe B, Maity SN . 1996 Mol. Cell. Biol. 16: 328–337
Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, Frommer M, Clark SJ . 1997 Cancer Res. 57: 2229–2237
Tanaka T, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamura M, Ishizaki K . 1998 Cancer Res. 58: 3429–3434
Tate PH, Bird AP . 1993 Curr. Opin. Genet. Dev. 3: 226–231
Thibodeau SN, Bren G, Schaid D . 1993 Science 260: 816–819
Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, Moslein G, Baker SM, Liskay RM, Burgart LJ, Honchel R, Halling KC . 1996 Cancer Res. 56: 4836–4840
Veigl ML, Kasturi L, Olechnowicz J, Ma A, Lutterbaugh JD, Periyasamy S, Li G, Drummond J, Modrich PL, Sedwick WD, Markowitz SD . 1998 Proc. Natl. Acad. Sci. USA 95: 8698–8702
Xiong Z, Laird PW . 1997 Nucl. Acids Res. 25: 2532–2534
Acknowledgements
We thank Drs Suzanne Crawley, Roger Erickson and James Gum for helpful discussions, suggestions and editorial assistance during the course of this work. We also thank Drs Sanker N Maity and Qianghua Hu for providing us with the plasmid carrying a dominant negative CBF mutant. This work was supported by the Theodora Betz Foundation, the Department of Veteran Affairs Medical Research Service and by Grant 24321 from the US Public Health Service, National Cancer Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deng, G., Chen, A., Pong, E. et al. Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression. Oncogene 20, 7120–7127 (2001). https://doi.org/10.1038/sj.onc.1204891
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204891
Keywords
This article is cited by
-
Recent Progress in Functional Genomic Studies of Depression and Suicide
Current Genetic Medicine Reports (2017)
-
An Epigenetic Mechanism of High Gdnf Transcription in Glioma Cells Revealed by Specific Sequence Methylation
Molecular Neurobiology (2016)
-
Epigenetics and colorectal cancer
Nature Reviews Gastroenterology & Hepatology (2011)
-
Comparative evaluation of the effects of 5-Aza-2’-deoxycytidine and Trichostatin A on reactivation of hMLH1 in COC1/DDP ovarian cancer cell line
Chinese Journal of Cancer Research (2009)
-
Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC
European Journal of Human Genetics (2008)